Schiavoni, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 1.250
AS - Asia 815
EU - Europa 659
SA - Sud America 161
Continente sconosciuto - Info sul continente non disponibili 37
AF - Africa 20
OC - Oceania 4
Totale 2.946
Nazione #
US - Stati Uniti d'America 1.204
SG - Singapore 379
CN - Cina 192
IT - Italia 169
BR - Brasile 131
DE - Germania 111
SE - Svezia 104
FR - Francia 99
VN - Vietnam 63
GB - Regno Unito 41
CA - Canada 29
IN - India 28
FI - Finlandia 27
JP - Giappone 27
IE - Irlanda 25
ID - Indonesia 22
BD - Bangladesh 19
KR - Corea 19
HK - Hong Kong 14
ES - Italia 13
RU - Federazione Russa 13
AR - Argentina 12
TR - Turchia 12
NL - Olanda 10
PL - Polonia 10
ZA - Sudafrica 8
IQ - Iraq 7
MX - Messico 7
AT - Austria 6
BE - Belgio 5
IR - Iran 5
SA - Arabia Saudita 5
UA - Ucraina 5
CZ - Repubblica Ceca 4
EC - Ecuador 4
MA - Marocco 4
PT - Portogallo 4
AU - Australia 3
AZ - Azerbaigian 3
CH - Svizzera 3
CO - Colombia 3
JM - Giamaica 3
NP - Nepal 3
PR - Porto Rico 3
VE - Venezuela 3
CL - Cile 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
UY - Uruguay 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GP - Guadalupe 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
LT - Lituania 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TC - Turks e Caicos 1
TN - Tunisia 1
Totale 2.910
Città #
Singapore 235
Ashburn 153
San Jose 115
Chandler 80
New York 51
Los Angeles 47
Beijing 46
The Dalles 38
Rome 34
Hefei 32
Frankfurt am Main 26
Dublin 23
Milan 23
Tokyo 23
Ho Chi Minh City 22
Hanoi 21
Jakarta 19
Lauterbourg 18
Marseille 18
Munich 18
Seoul 18
Helsinki 16
Hong Kong 13
Boardman 12
Boston 12
Council Bluffs 12
Houston 12
São Paulo 12
Dallas 11
Paris 11
Chicago 10
Denver 10
Montreal 10
Nuremberg 10
Santa Clara 10
Buffalo 9
Kent 9
Moscow 9
Phoenix 9
Poplar 9
Brooklyn 8
Memphis 8
North Bergen 8
Orem 8
Princeton 8
Toronto 8
Atlanta 7
Jacksonville 7
Nanjing 7
Redmond 7
Seattle 7
Bremen 6
Guarulhos 6
Hyderabad 6
Macerata 6
Nürnberg 6
Paderno Dugnano 6
Pune 6
Turku 6
Wilmington 6
Baghdad 5
Chennai 5
Naples 5
Shanghai 5
Stockholm 5
Cattolica 4
Da Nang 4
Dearborn 4
Düsseldorf 4
Izmir 4
Johannesburg 4
Lancaster 4
Lisbon 4
Rio de Janeiro 4
San Francisco 4
Tianjin 4
Amsterdam 3
Baku 3
Belo Horizonte 3
Bogotá 3
Brussels 3
Charlotte 3
Chelsea 3
Hangzhou 3
Hillsboro 3
Kathmandu 3
Kunming 3
Lappeenranta 3
London 3
Madrid 3
Mumbai 3
Newark 3
Palermo 3
Redwood City 3
Roubaix 3
Salvador 3
San Diego 3
San Mateo 3
Trieste 3
Warsaw 3
Totale 1.544
Nome #
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 326
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 188
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 167
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 162
Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study 154
The role of inflammatory bowel disease nurses for patients on biologic therapy during the COVID-19 pandemic 150
Therapy experiences and preferences among patients with anemia: Results of a cross-sectional survey among Italian patients with inflammatory bowel disease 147
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 136
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 132
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 126
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 121
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study 118
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 118
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 118
The awareness of the IBD nurse position among patients from an Italian tertiary IBD centre 115
Changes in the intestinal microbiota in patients with a major depressive episode and ulcerative colitis 110
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study 93
Nonmedical switch of anti-TNF-α biosimilars has no major clinical, pharmacokinetic and psychological impact on patients with IBD - the SAFER Study 91
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 87
The educational role of IBD nurses in Italy in vaccinations: do not miss the moment for COVID-19 79
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 76
The inflammatory bowel disease care manager: Italian state of the art 75
Timing of biologic prophylaxis and postoperative recurrence in Crohn's disease: A real-life cohort study using propensity score weighting 26
Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up Study 18
Monitoring the psychopathological profile of inflammatory bowel disease patients treated with biological agents: a pilot study 13
Totale 2.946
Categoria #
all - tutte 12.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.316


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 6 4 3 3 1 6 0 18 21 21
2022/2023276 44 32 11 35 20 17 28 27 27 6 11 18
2023/2024248 9 35 20 17 12 40 19 7 15 17 29 28
2024/2025521 9 11 45 19 35 18 33 20 46 68 110 107
2025/20261.327 192 51 88 193 226 65 195 59 87 72 54 45
2026/2027304 22 213 69 0 0 0 0 0 0 0 0 0
Totale 2.946